Tavec Pharmaceuticals is developing injectable therapies to treat cancers. Tavec's exosome-mediated technology enables the delivery by injection of anti-cancer molecules, including regulatory RNA, directly to cancer cells to disrupt growth and metastasis. Exosomes are small, naturally occurring vesicles which can be grown to enable